Scholarly Index
Myong Cheol Lim
National Cancer Center; 6,519 total citations; 444 total publications; best world rank #27
National Cancer Center
6,519Total citations
444Total publications
42H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ovarian cancer diagnosis and treatment | Lifetime | 526 | KR 13 | 97.87 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 402 | KR 11 | 98.05 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 192 | KR 2 | 97.41 |
| Cervical Cancer and HPV Research | Lifetime | 722 | KR 12 | 96.99 |
| Uterine Myomas and Treatments | Lifetime | 836 | KR 25 | 95.37 |
| Multiple and Secondary Primary Cancers | Lifetime | 815 | KR 22 | 92.68 |
| PARP inhibition in cancer therapy | Lifetime | 912 | KR 11 | 91.28 |
| Intraperitoneal and Appendiceal Malignancies | 2021-2025 | 27 | KR 1 | 96.79 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 83 | KR 4 | 98.57 |
| PARP inhibition in cancer therapy | 2021-2025 | 109 | KR 3 | 95.96 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 224 | KR 7 | 96.37 |
| Cervical Cancer and HPV Research | 2021-2025 | 247 | KR 2 | 94.65 |
| BRCA gene mutations in cancer | 2021-2025 | 345 | KR 2 | 91.07 |
| Uterine Myomas and Treatments | 2021-2025 | 387 | KR 15 | 89.39 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 280 | KR 9 | 75.89 |
| Testicular diseases and treatments | 2021-2025 | 533 | KR 3 | 70.44 |